Alsayed Badr A, Mir Rashid
Internal Medicine, University of Tabuk, Tabuk, SAU.
Molecular Oncology, Genetics and Translational Medicine, Faculty of Applied Medical Sciences, Tabuk, SAU.
Cureus. 2022 Mar 30;14(3):e23636. doi: 10.7759/cureus.23636. eCollection 2022 Mar.
Genetic susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality continues to evolve. This report presents a case of an apparently healthy male adult who developed severe coronavirus disease 2019 (COVID-19) and a study on relevant genetic mutations, namely, angiotensin-converting enzyme 2 (ACE2-rs4646994 I/D) gene, glutathione S-transferase (GST) M1 and T1 gene, and miR-423 rs6505162 C>A gene polymorphism. Results showed that the ACE-DD genotype of ACE2, (GSTM1+/+) (GSTT1-/-) genotype of GST gene, and CA genotype (heterozygosity) of miR-423 rs6505162 genes, which were found in the patient, could be independent risk factors of severe COVID-19, even without comorbidities.
对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)发病和死亡的遗传易感性仍在不断演变。本报告介绍了一例表面健康的成年男性患重症2019冠状病毒病(COVID-19)的病例以及一项关于相关基因突变的研究,即血管紧张素转换酶2(ACE2-rs4646994 I/D)基因、谷胱甘肽S-转移酶(GST)M1和T1基因以及miR-423 rs6505162 C>A基因多态性。结果显示,在该患者中发现的ACE2的ACE-DD基因型、GST基因的(GSTM1+/+)(GSTT1-/-)基因型以及miR-423 rs6505162基因的CA基因型(杂合性),即使在没有合并症的情况下,也可能是重症COVID-19的独立危险因素。